Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Pancreatic Intraductal Neoplasms, Pancreatic Intraductal Papillary Mucinous Neoplasm, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm	Recruiting	Not stated	2025-09-03		NCT06574373

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Azienda Ospedaliera Universitaria Integrata Verona	33
Fondazione Policlinico Universitario Agostino Gemelli IRCCS	491
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale	16
University of Messina	9

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fondazione Policlinico Gemelli	Roma	Italy	2
IRCCS Fondazione Policlinico Universitario A. Gemelli	Rome	Italy	1